Contents:
Tranexamic acid for bleeding in palliative care
Introduction
These guidelines are intended to guide and support professionals caring for patients with a palliative diagnosis who are bleeding and may benefit from the use of tranexamic acid.
This guidance should be used in conjunction with other SPAGG guidelines and any other relevant policies/procedures relating to the care of the patient.
To provide clear guidelines for the safe and effective use of tranexamic acid in palliative care for the prevention and treatment of bleeding. These guidelines aim to reduce anxiety, relieve suffering and optimise symptom management as well as providing support for healthcare professionals.
Disclaimer
These Guidelines are intended for use by healthcare professionals and the expectation is that they will use clinical judgement, medical, and nursing knowledge in applying the general principles and recommendations contained within. They are not meant to replace the many available texts on the subject of palliative care.
Some of the management strategies describe the use of drugs outside their licensed indications. They are, however, established and accepted good practice. Please refer to the current BNF for further guidance.
Whilst SPAGG takes every care to compile accurate information , we cannot guarantee its correctness and completeness, and it is subject to change. We do not accept responsibility for any loss, damage or expense resulting from the use of this information.